Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. - Wikidata - wikimedia - TriplyDB

Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein.

Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein.

http://www.wikidata.org/entity/Q33827148

about

The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5 Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein.Antiviral actions of interferons Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light-chain-related protein PAT1 results in the redistribution of both polypeptides Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription Oncolytic virus therapy: A new era of cancer treatment at dawn Inhibition of Cellular 2'-5' Oligoadenylate Synthetase by the Herpes Simplex Virus Type 1 Us11 Protein Negative regulation of cytoplasmic RNA-mediated antiviral signaling Viruses as nanomedicine for cancer Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replication Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms Suppression of proinflammatory cytokine expression by herpes simplex virus type 1.ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41 Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus In vivo replication of an ICP34.5 second-site suppressor mutant following corneal infection correlates with in vitro regulation of eIF2 alpha phosphorylation.Viruses and the type I interferon antiviral system: induction and evasion.A Functional Type I Interferon Pathway Drives Resistance to Cornea Herpes Simplex Virus Type 1 Infection by Recruitment of Leukocytes Genetic metamorphosis of herpes simplex virus-1 into a biological therapeutic for human cancer.Activation and evasion of innate antiviral immunity by herpes simplex virus Innate and adaptive immune responses to herpes simplex virus Herpesviruses and autophagy: catch me if you can!Evasion of early antiviral responses by herpes simplex viruses.RNA binding properties of the US11 protein from four primate simplexviruses Neutralizing innate host defenses to control viral translation in HSV-1 infected cells.Increased susceptibility to DNA virus infection in mice with a GCN2 mutation Cellular autophagy: surrender, avoidance and subversion by microorganisms.The Us3 Protein of Herpes Simplex Virus 1 Inhibits T Cell Signaling by Confining Linker for Activation of T Cells (LAT) Activation via TRAF6 Protein.Mammalian alphaherpesvirus miRNAs.HSV ICP0 recruits USP7 to modulate TLR-mediated innate response Designing Herpes Viruses as Oncolytics.Vaccines in cancer: GVAX, a GM-CSF gene vaccine.Viruses with deletions in antiapoptotic genes as potential oncolytic agents.Regulation of PACT-Mediated Protein Kinase Activation by the OV20.0 Protein of Orf Virus.To replicate or not to replicate: achieving selective oncolytic virus replication in cancer cells through translational control.Autophagy and antiviral immunity Functional signatures of protective antiviral T-cell immunity in human virus infections.

P2860

Q24292276-959ABBC5-EF6C-456A-B6F8-C4538229441B Q24304261-9B4BD55B-E7A7-45D2-A2AA-3C76402B6B6F Q24538727-44C27A43-C379-4398-82B1-AF0FDF9A1810 Q24550676-859C7A4B-DC9C-458D-B6D8-D3796015ED14 Q24683333-5DA7B5F6-9FF2-4C7A-B3D6-9E44731449A9 Q24806541-04D84160-5068-4CD0-8C41-8081449FF1CD Q26739714-685F94AF-7420-41EA-9D67-450EDDB2127C Q27478374-1F3B9F09-E32F-4F3E-BC9B-66F01919B30B Q27487296-AF5016D1-373D-4185-B838-AC91B25962BC Q27690636-12EAC59B-E3E0-474B-8A3E-94921C368045 Q30431312-F54DEAD7-3FB9-4B52-A1AB-76E026777C6D Q33826815-DEC905C0-4408-48FF-A9B6-F22E4C039F83 Q34142890-3FC62368-D611-4C9D-AD0D-0BB70B4CD9D7 Q34152457-903501DB-D3B6-4476-829E-A7156BF8F02B Q34178661-EFB6732E-3D32-46E0-874F-DC26D24FA2C2 Q34208420-376B1B57-29C9-497D-B31E-AD99CF4AF2B2 Q34261465-C0B6D21C-BEE3-4366-95DE-7CF251C1D4FD Q34338614-069C5371-4856-425B-B8CB-0B71E988FDAA Q34858111-8E28F8E8-D429-4CDA-B217-CBE6D790702D Q35027514-FD89EC29-3E09-44B2-81E2-3FD844781C7E Q35058178-A5933E9D-8D6A-4E42-8D43-CB8A3BD9C947 Q35116166-03F333BF-EDEB-4355-83A1-CE41E9E9A353 Q35259878-D07301C0-3CCA-4FA5-AC3E-686F2F6D4221 Q35260078-E79BF25A-E048-4E84-B00E-B822F8D1A055 Q35260271-672C4C00-FC7F-4491-8B7C-FC44844AD366 Q35414669-67C6C65F-5BFF-43FE-9671-05AFE760B740 Q35576662-D58EDE44-1437-4B01-8525-A34EBF4D8237 Q35613824-AF0BCD58-3930-4D8B-A6B5-DCAB3631503A Q35689654-78C0DECF-AC62-4FE6-BB66-AEDD1C03FEBE Q35697536-C479CB27-538D-4912-8CAE-D53D8C979021 Q35860680-F48E1ADA-562B-4338-9300-45E2EAB119DB Q36057726-D5E2D303-B002-43B0-9CFB-933C2956EC00 Q36105979-7486E774-A3C7-4AE0-BE05-1F9B8EAC2208 Q36142487-F18041FB-DE15-4469-9811-39BC509898D6 Q36198632-1571B098-C14C-4BC3-B5A9-4E9C5C984CB8 Q36254857-F9320420-2086-40F9-A2A8-E14CD93ACE6D Q36281864-1EC1289D-D99E-45F0-BBD6-24FECD2CBF68 Q36318160-CFE39E52-6858-4C02-9A6F-7D420C85D60A Q36503156-E0EB6941-DE85-414E-8777-8C8B5C1CF4D9 Q36529008-3F46F19F-BE2B-4FFF-AC86-0F8ED438D03E

P2860

Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein.

http://www.wikidata.org/entity/Q33827148

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@ast

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@en

type

label

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@ast

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@en

prefLabel

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@ast

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@en

P1433

Q33827148-BB7C82BC-C0F5-45DF-B1F6-AAB4FCE6F926

P1476

Q33827148-0FF00F36-7477-40F1-A237-D5E6EEA2F513

P2093

Q33827148-70B7306A-F8C3-49CC-B955-6BCF36367C1C

Q33827148-797F0969-28A1-4368-A836-A76295484224

Q33827148-CE838920-4DA3-49AD-89F3-F0C6B9A0AF2E

Q33827148-F1468326-BD60-4E9D-85F5-DFBB20147CB3

P2860

Q33827148-071B732C-88F3-4ED2-9B5A-48D0FD41E58E

Q33827148-0724DF47-3C03-45B7-9BBC-4B5126AB1C59

Q33827148-141FDF05-ABAC-4B1A-ABDD-8E42EDB9B5B2

Q33827148-19B1E06A-F326-4607-BABD-30AA528BC6DD

Q33827148-1AEBC8CA-E050-4DD3-8BAC-E89A8418D054

Q33827148-22F6D25B-7CFE-4A70-BC2F-E2751DA34DDA

Q33827148-2FA3947E-CA66-4387-9F9F-32DCD047FFC3

Q33827148-33AB5541-98D7-40AF-AF80-2AA65E4CC652

Q33827148-4553C314-5CF8-443A-A099-8FEFD05B6408

Q33827148-4C0BCDE6-2A77-43D8-933F-2838781FB64D

P304

Q33827148-0298E443-C850-4A25-8807-935C8FC34A13

P31

Q33827148-24A23F02-952C-4275-86A1-8F59EA0D0CD8

P356

Q33827148-EA3ED60E-A902-4991-B12E-3EBFEE93B097

P433

Q33827148-DA9D1B4D-097F-4EC7-8AF0-2C6B8CA6F3B6

P478

Q33827148-943B0FAD-CC38-4B15-B594-877A1AB82B7E

P577

Q33827148-90D57501-88DE-435B-AE2A-F91BEF4C5312

P698

Q33827148-027BEAE7-951A-4142-8AE4-3C61AED01D04

P932

Q33827148-8E8A6675-10C4-4803-AE08-C9641BD6DF6A

P356

JVI.74.23.11215-11221.2000

P1433

Journal of Virology

P1476

Inhibition of PKR activation b ...... lex virus type 1 Us11 protein.

@en

P2093

D Khoo

http://www.w3.org/2001/XMLSchema#string

I Mohr

http://www.w3.org/2001/XMLSchema#string

J Poppers

http://www.w3.org/2001/XMLSchema#string

M Mulvey

http://www.w3.org/2001/XMLSchema#string

P2860

PACT, a protein activator of the interferon-induced protein kinase, PKR.

A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function

A conserved double-stranded RNA-binding domain

Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region

A novel RNA-binding motif in influenza A virus non-structural protein 1

Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein

PKR; a sentinel kinase for cellular stress

RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling

A herpesvirus ribosome-associated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function.

Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor.

P304

11215-11221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.74.23.11215-11221.2000

http://www.w3.org/2001/XMLSchema#string

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11070019

http://www.w3.org/2001/XMLSchema#string

P932

113216

http://www.w3.org/2001/XMLSchema#string